🏥 Health 7h ago

GLP-1, Amylin Analog Combo Cuts Blood Sugar, Weight in Diabetes Trials

MedPage Today
Medical news for professionals
View Channel →
GLP-1, Amylin Analog Combo Cuts Blood Sugar, Weight in Diabetes Trials
Source ↗ 👁 1 💬 0
(MedPage Today) -- NEW ORLEANS -- A fixed-dose combination of novel amylin analog cagrilintide and semaglutide, given once weekly, lowered blood glucose and weight in various populations with type 2 diabetes.
The combination injectable, dubbed...

Comments (0)

Sign in to join the discussion

More Like This

Helping Teen Girls Dream Big Without Burning Out
Psychology Today: The Latest · 6h ago
Quick Fixes for Anxiety
Psychology Today: The Latest · 6h ago
Large Study Links GLP-1s to Lower Risk of Multiple Cancers
MedPageToday.com - medical news for physicians · 6h ago
We Built the Machine, Then Blamed the Kids for Unplugging
Psychology Today: The Latest · 7h ago
Are Older People Really Happier Than Younger People?
Psychology Today: The Latest · 7h ago
How to Get Beyond an Attachment to Right and Wrong
Psychology Today: The Latest · 7h ago